Prescription drug · ANDA
Carisoprodol NDC 72189-386
Carisoprodol 350 mg/1 · Tablet · Oral · Direct_Rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72189-386-30 | 7218903863072189038630 | 30 TABLET in 1 BOTTLE (72189-386-30)Marketed from Oct 12, 2022 | |
| 72189-386-72 | 7218903867272189038672 | 120 TABLET in 1 BOTTLE (72189-386-72)Marketed from Oct 12, 2022 | |
| 72189-386-90 | 7218903869072189038690 | 90 TABLET in 1 BOTTLE (72189-386-90)Marketed from Oct 12, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carisoprodol
- Generic name (nonproprietary)
- carisoprodol
- Active ingredients
- Carisoprodol — 350 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Direct_RxNDC labeler code 72189
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040792
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Centrally-mediated Muscle Relaxation (Physiologic effect)
- Identifiers
- Product ID 72189-386_2c4cda4e-be1d-b27b-e063-6394a90a8e19SPL ID 2c4cda4e-be1d-b27b-e063-6394a90a8e19SPL set ID ead8294f-fd27-5c3d-e053-2a95a90a64afRxCUI 197446UNII 21925K482H
- Pharmacologic class
- Muscle Relaxant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472189038630followed by a unit qualifier and the quantityPackage 72189-0386-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Carisoprodol tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Limitation of Use Carisoprodol tablets should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [see DOSAGE AND ADMINISTRATION (2)].
Excerpt only. Read the full label for complete information.
About NDC 72189-386
- What is NDC 72189-386?
- 72189-386 is the product NDC for Carisoprodol, Carisoprodol 350 mg/1 tablet, listed with the FDA by Direct_Rx. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Carisoprodol.
- What is the active ingredient?
- Carisoprodol.
- Who is the labeler?
- Direct_Rx, NDC labeler code 72189. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Carisoprodol?
- 46 other product NDCs are listed under this name. See all Carisoprodol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Carisoprodol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Carisoprodol | Carisoprodol 350 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | 60760-397 | 60760-0397-90 |
| Carisoprodol | Carisoprodol 250 mg/1 | TabletOral | Westminster Pharmaceuticals, LLC | 69367-419 | 69367-0419-01 |
| Carisoprodol | Carisoprodol 350 mg/1 | TabletOral | Westminster Pharmaceuticals, LLC | 69367-420 | 69367-0420-0169367-0420-05 |
| Carisoprodol | Carisoprodol 350 mg/1 | TabletOral | Northwind Health Company, LLC | 82868-062 | 82868-0062-30 |
| carisoprodol | Carisoprodol 350 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3792 | 70518-3792-00 |
| Carisoprodol | Carisoprodol 350 mg/1 | TabletOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0291 | 80425-0291-0180425-0291-0280425-0291-03 |
| Carisoprodol | Carisoprodol 350 mg/1 | TabletOral | Directrx | 72189-310 | 72189-0310-3072189-0310-6072189-0310-72+1 more |
| Carisoprodol | Carisoprodol 350 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2800 | 70518-2800-00 |
| Carisoprodol | Carisoprodol 350 mg/1 | TabletOral | Medsource Pharmaceuticals | 45865-233 | 45865-0233-3045865-0233-60 |
| Carisoprodol | Carisoprodol 350 mg/1 | TabletOral | A-S Medication Solutions | 50090-5953 | 50090-5953-05 |
Other NDCs under ANDA 040792
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| carisoprodol | Carisoprodol 250 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-693 |
| carisoprodol | Carisoprodol 350 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-158 |
| carisoprodol | Carisoprodol 350 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3792 |
| carisoprodol | Carisoprodol 250 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-780 |
| carisoprodol | Carisoprodol 350 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-781 |
| carisoprodol | Carisoprodol 350 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3421 |
| carisoprodol | Carisoprodol 350 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-9613 |
| carisoprodol | Carisoprodol 250 mg/1 | TabletOral | Asclemed USA, Inc. | 76420-852 |
| carisoprodol | Carisoprodol 350 mg/1 | TabletOral | Asclemed USA, Inc. | 76420-853 |